NASDAQ : OSUR
OraSure Technologies, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 3.94 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 271.74M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 271.74M |
| Enterprise Value | 123.25M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 9, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 68.97M |
| Shares Outstanding | 68.97M |
| Shares Change (YoY) | -5.25% |
| Shares Change (QoQ) | +0.69% |
| Owned by Insiders (%) | 6.51% |
| Owned by Institutions (%) | 76.17% |
| Float | 56.94M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.42 |
| Forward PS | 2.17 |
| PB Ratio | 0.86 |
| P/TBV Ratio | 1.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 8.88 |
| Quick Ratio | 7.48 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -39.45 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -14.07% |
| Return on Assets (ROA) | -11.04% |
| Return on Invested Capital (ROIC) | -44.69% |
| Return on Capital Employed (ROCE) | -21.20% |
| Weighted Average Cost of Capital (WACC) | 10.15% |
| Revenue Per Employee | $224,824 |
| Profits Per Employee | -$98,252 |
| Employee Count | 500 |
| Asset Turnover | 0.28 |
| Inventory Turnover | 2.03 |
Taxes
| Measure | Value |
|---|
| Income Tax | -120,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.06 |
| 52-Week Price Change | +41.22% |
| 50-Day Moving Average | 3.76 |
| 200-Day Moving Average | 3.51 |
| Relative Strength Index (RSI) | 52.01 |
| Average Volume (20 Days) | 620,154 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.73M |
| Short Previous Month | 2.93M |
| Short % of Shares Out | 3.96% |
| Short % of Float | 4.80% |
| Short Ratio (days to cover) | 4.50 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 112.41M |
| Gross Profit | 47.93M |
| Operating Income | -71.13M |
| Pretax Income | -49.25M |
| Net Income | -49.13M |
| EBITDA | -61.56M |
| EBIT | -71.13M |
| Loss Per Share | -$0.69 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 160.58M |
| Total Debt | 12.09M |
| Net Cash | 148.49M |
| Net Cash Per Share | $2.15 |
| Equity (Book Value) | 317.78M |
| Book Value Per Share | 4.61 |
| Working Capital | 197.82M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -42.88M |
| Capital Expenditures | -5.18M |
| Depreciation & Amortization | 9.57M |
| Net Borrowing | -80,000 |
| Free Cash Flow | -48.07M |
| FCF Per Share | -$0.70 |
Margins
| Measure | Value |
|---|
| Gross Margin | 42.63% |
| Operating Margin | -63.27% |
| Pretax Margin | -43.81% |
| Profit Margin | -43.70% |
| EBITDA Margin | -54.76% |
| EBIT Margin | -63.27% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 5.25% |
| Shareholder Yield | n/a |
| Earnings Yield | -17.62% |
| FCF Yield | -17.69% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $5.50 |
| Price Target Difference | 39.59% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 6.96% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Apr 8, 1987 |
| Split Type | Forward |
| Split Ratio | 3:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 2.63 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |